K. Ozdilli Et Al. , "Do UCP2, IL-17, mi196a2, and NR3C1 gene variants contribute to the risk of microtia? A preliminary study in Turkish population," European Biotechnology Congress , vol.280, Athens, Greece, 2018
Ozdilli, K. Et Al. 2018. Do UCP2, IL-17, mi196a2, and NR3C1 gene variants contribute to the risk of microtia? A preliminary study in Turkish population. European Biotechnology Congress , (Athens, Greece).
Ozdilli, K., BEKERECİOĞLU, M., NURSAL, A. F., PEHLİVAN, M., Sever, U., Buyukgural, B., ... Pehlivan, S.(2018). Do UCP2, IL-17, mi196a2, and NR3C1 gene variants contribute to the risk of microtia? A preliminary study in Turkish population . European Biotechnology Congress, Athens, Greece
Ozdilli, Kursat Et Al. "Do UCP2, IL-17, mi196a2, and NR3C1 gene variants contribute to the risk of microtia? A preliminary study in Turkish population," European Biotechnology Congress, Athens, Greece, 2018
Ozdilli, Kursat Et Al. "Do UCP2, IL-17, mi196a2, and NR3C1 gene variants contribute to the risk of microtia? A preliminary study in Turkish population." European Biotechnology Congress , Athens, Greece, 2018
Ozdilli, K. Et Al. (2018) . "Do UCP2, IL-17, mi196a2, and NR3C1 gene variants contribute to the risk of microtia? A preliminary study in Turkish population." European Biotechnology Congress , Athens, Greece.
@conferencepaper{conferencepaper, author={Kursat Ozdilli Et Al. }, title={Do UCP2, IL-17, mi196a2, and NR3C1 gene variants contribute to the risk of microtia? A preliminary study in Turkish population}, congress name={European Biotechnology Congress}, city={Athens}, country={Greece}, year={2018}}